Rankings
▼
Calendar
HOWL Q1 2025 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
HOWL
Werewolf Therapeutics, Inc.
$35M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$426,000
Operating Income
-$18M
Net Income
-$18M
EPS (Diluted)
$-0.40
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$107M
Total Liabilities
$50M
Stockholders' Equity
$57M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$742,000
-100.0%
Gross Profit
-$426,000
$278,000
-253.2%
Operating Income
-$18M
-$17M
-4.8%
Net Income
-$18M
-$16M
-11.7%
← Q4 2024
All Quarters
Q2 2025 →